Should we screen for cirrhosis?

BMJ. 2017 Jul 12:358:j3233. doi: 10.1136/bmj.j3233.

Authors

Mark Hudson¹, Nick Sheron², Ian A Rowe³, Gideon M Hirschfield⁴

Affiliations

¹ Freeman Hospital, Newcastle upon Tyne, UK Mark.Hudson@nuth.nhs.uk i.a.c.rowe@leeds.ac.uk.
² Southampton General Hospital, University of Southampton, UK.
³ Leeds Institute for Data Analytics, University of Leeds, UK.
⁴ Centre for Liver Research, NIHR Biomedical Research Centre, University of Birmingham, Birmingham, UK.

PMID: 28701337
DOI: 10.1136/bmj.j3233

No abstract available

MeSH terms

Health Policy*
Humans
Liver Cirrhosis / diagnosis*
Liver Cirrhosis / epidemiology
Liver Cirrhosis / therapy
Mass Screening*
Risk Assessment
United Kingdom / epidemiology